People are embracing a more sedentary lifestyle as the middle class expands and urbanization accelerates, leading to the need for more drugs–especially oral solid dose (OSD) medicines, according to a report by Research & Markets. Obesity rates and occurrences of diseases like diabetes are rising as a result of this. According to the World Health Organization, the prevalence of chronic disease will rise by 57% by 2027.
From 143 million in 2019 to 426 million in 2050, the number of people aged 80 and up is expected to treble. Eastern and South-Eastern Asia's population aged 65 and above nearly doubled from 6% in 1990 to 11% in 2019, while Latin America and the Caribbean's population aged 65 and above nearly doubled from 5% in 1990 to 9% in 2019. The growing geriatric population around the world is also expected to propel market growth in the forecast period.roke, chronic obstructive pulmonary disease (COPD), and type 2 diabetes being the most common. Smoking, alcohol usage, sedentary activity, and poor nutritional intake are all significant contributors to these diseases. Oral drug delivery systems are expected to become more popular as the prevalence of chronic diseases rises around the world.